PharmaLedger Press Release Announces Transition of Project to PharmaLedger Association
PharmaLedger has published a new press release announcing its strategy to sustain the Project’s outcomes after its completion in December 2022.
PharmaLedger has published a new press release announcing its strategy to sustain the Project’s outcomes after its completion in December 2022.
The PharmaLedger Project’s 29 consortium members have formally endorsed the creation of the PharmaLedger Association (PLA), a not-for-profit organisation that will carry forward the vision of the Project. Based in Basel, Switzerland, PLA will help launch the digital products developed during the Project, starting with the Electronic Product Information tool, and incubate new blockchain-based healthcare solutions that bring value to patients and all healthcare stakeholders.
From October 2022 to January 2023, PharmaLedger will implement its approved sustainability plan and actively recruit members to join the PharmaLedger Association.
Read more about the structure and aims of PLA in the full press release.
Interested in becoming a member of PLA? Sign up below and be the first to receive more information.